The global sevoflurane market is expected to reach USD 1252.2 billion by 2030, at a CAGR of 4.5% during the forecast period 2021 to 2030. It is anticipated that inorganic activities such as collaborations, agreements, acquisitions, and others will be among the primary growth drivers of the global sevoflurane market throughout the forecast period. Other growth drivers include rising research and development activities, rising product launches and approvals, and rising product launches.